Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+S
NCT: NCT01984710 · ACTIVE_NOT_RECRUITING
Brief Summary
The goal of this study is to use the Activa Primary Cell + Sensing (PC+S) device to study Latent Field Potential (LFP) in the brains of people with Treatment Resistant Depression (TRD) before and during active stimulation. The ultimate goal is to understand the neural network that causes TRD and the changes that DBS cause in that network that results in the antidepressant effects.
Frequently Asked Questions
What is Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+S?
Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+S is a clinical trial registered under NCT01984710. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT01984710?
The current status of NCT01984710 (Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+S) is: ACTIVE_NOT_RECRUITING.
When did Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+S start?
Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+S started on 2013-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.